SuperworthRadNet profit margin RDNT
Gross, operating and net profit as a share of revenue over the last twelve months, from 2011.
- Net margin, 12 months
- −0.9%
- Operating margin, 12 months
- 3.1%
- Net margin on a year earlier
- −0.1 pts
- Peer median
- 10.1%
Over the twelve months to Jun 30, 2026, RadNet kept −0.9% of its revenue as net profit, with an operating margin of 3.1%.
Five years earlier its net margin was 2.0%.
The median for 10 diagnostics and research stocks of a similar size is 10.1%.
Profit margin over time
Fiscal year by fiscal year
| Fiscal year | Net margin | Operating margin | Gross margin |
|---|---|---|---|
| FY2025 | −0.9% | 3.0% | n/a |
| FY2024 | 0.2% | 5.7% | n/a |
| FY2023 | 0.2% | 6.1% | n/a |
| FY2022 | 0.7% | 3.2% | n/a |
| FY2021 | 1.9% | 6.3% | n/a |
| FY2020 | −1.4% | 3.3% | n/a |
| FY2019 | 1.3% | 6.1% | 13.4% |
| FY2018 | 3.3% | 3.2% | 11.0% |
| FY2017 | 0.0% | 5.4% | 13.0% |
| FY2016 | 0.8% | 4.4% | 12.3% |
| FY2015 | 1.0% | 4.8% | 12.5% |
| FY2014 | 0.2% | 7.4% | 16.0% |
| FY2013 | 0.3% | 6.2% | 14.8% |
| FY2012 | 9.7% | 6.8% | 18.5% |
| FY2011 | 1.2% | 8.3% | 21.3% |
Quarter by quarter
| Quarter | Ended | Net margin, 12 months | Change on a year | Operating margin |
|---|---|---|---|---|
| Q2 FY26 | −0.9% | −0.1 pts | 3.1% | |
| Q1 FY26 | −0.7% | +1.1 pts | 2.9% | |
| Q4 FY25 | −0.9% | −1.1 pts | 3.0% | |
| Q3 FY25 | −0.6% | −0.4 pts | 3.0% | |
| Q2 FY25 | −0.8% | −1.4 pts | 3.4% | |
| Q1 FY25 | −1.7% | −3.0 pts | 3.7% | |
| Q4 FY24 | 0.2% | −0.0 pts | 5.7% | |
| Q3 FY24 | −0.2% | −0.5 pts | 5.9% | |
| Q2 FY24 | 0.6% | +1.4 pts | 6.6% | |
| Q1 FY24 | 1.3% | +2.2 pts | 6.2% | |
| Q4 FY23 | 0.2% | −0.6 pts | 6.1% | |
| Q3 FY23 | 0.3% | −0.3 pts | 6.1% |
Against its peers
Companies in Medical - Diagnostics & Research nearest RadNet's size, closest first, today.
| Company | Profit margin |
|---|---|
| RDNTRadNet | −0.9% |
| BLLNBillionToOne | 9.5% |
| LNTHLantheus | 17.7% |
| VCYTVeracyte | 20.4% |
| CDNACareDx | 24.2% |
| CAICaris Life Sciences | 10.6% |
| BIOBio-Rad Laboratories | 8.6% |
| RVTYRevvity | 8.2% |
| MEDPMedpace | 17.7% |
| LHLabcorp | 7.0% |
| DGXQuest Diagnostics | 9.2% |
| Peer median | 10.1% |
Where RadNet ranks
What the profit margin tells you
Profit as a share of revenue at three levels: gross (after making the product), operating (after running the business) and net (after everything, including tax and interest).
Compare within an industry. 10% is superb for a retailer and poor for a software company.
More on RadNet
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.